High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing Hemodialysis
Open Access
- 30 January 2015
- journal article
- research article
- Published by S. Karger AG in Cardiorenal Medicine
- Vol. 5 (2), 89-95
- https://doi.org/10.1159/000371661
Abstract
Objective: Circulating soluble tumor necrosis factor receptors 1 and 2 (sTNFR1 and sTNFR2) are associated with chronic kidney disease (CKD) progression in patients with CKD or diabetes, and with higher mortality. However, data in patients with end-stage renal disease are scarce. Therefore, we analyzed serum levels of sTNFR1 and sTNFR2 and investigated their association with inflammatory markers and mortality in dialysis patients. Research Design and Methods: This was a longitudinal cohort study of 207 prevalent patients (median age 66 years, 56% men) undergoing hemodialysis in Stockholm, Sweden. Demographics, clinical characteristics, including comorbidities and laboratory data, were obtained at baseline, together with prospective follow-up for mortality. Results: The median sTNFR1 and sTNFR2 levels were 17,680 ng/l [95% confidence interval (CI) 17,023-18,337] and 24,450 ng/l (95% CI 23,721-25,179), respectively. During a follow-up of 31 months (interquartile range, 21-38), 77 patients died. There was no association between the levels of sTNFRs and mortality in Cox regression models, and no consistent trend towards higher or lower mortality was seen in Laplace regression models. sTNFR1 and sTNFR2 levels were highly associated with other inflammatory markers including interleukin-6, pentraxin 3 and TNF-α. Conclusions: Prevalent hemodialysis patients have several-fold higher levels of sTNFRs compared to previous studies in CKD stage 4 patients. As no consistent association between TNFR and mortality was observed, clinical implications of measuring these receptors to predict outcome end-stage renal disease patients provide limited results.Keywords
This publication has 23 references indexed in Scilit:
- Association of Serum Concentration of TNFR1 With All-Cause Mortality in Patients With Type 2 Diabetes and Chronic Kidney Disease: Follow-up of the SURDIAGENE CohortDiabetes Care, 2014
- Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to MacroalbuminuriaDiabetes Care, 2013
- Tumour necrosis factor receptor 1 and mortality in a multi-ethnic cohort: the Northern Manhattan StudyAge and Ageing, 2013
- Association between serum soluble TNFα receptors and renal dysfunction in type 2 diabetic patients without proteinuriaDiabetes Research and Clinical Practice, 2011
- Chronic kidney disease: a public health priority and harbinger of premature cardiovascular diseaseJournal of Internal Medicine, 2010
- Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient SurvivalAmerican Journal of Kidney Diseases, 2009
- Immunosuppressive Treatment Protects Against Angiotensin II-Induced Renal DamageThe American Journal of Pathology, 2002
- Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 DiabetesEndocrine Reviews, 2002
- Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance.Diabetes, 1998
- Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathyKidney International, 1991